LU67790A1 - - Google Patents

Info

Publication number
LU67790A1
LU67790A1 LU67790A LU67790DA LU67790A1 LU 67790 A1 LU67790 A1 LU 67790A1 LU 67790 A LU67790 A LU 67790A LU 67790D A LU67790D A LU 67790DA LU 67790 A1 LU67790 A1 LU 67790A1
Authority
LU
Luxembourg
Application number
LU67790A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU67790A1 publication Critical patent/LU67790A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
LU67790A 1972-06-15 1973-06-14 LU67790A1 (enrdf_load_html_response)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (1)

Publication Number Publication Date
LU67790A1 true LU67790A1 (enrdf_load_html_response) 1973-08-16

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
LU67790A LU67790A1 (enrdf_load_html_response) 1972-06-15 1973-06-14

Country Status (9)

Country Link
BE (1) BE800899R (enrdf_load_html_response)
CA (1) CA1040619A (enrdf_load_html_response)
DE (1) DE2330342A1 (enrdf_load_html_response)
DK (1) DK136157B (enrdf_load_html_response)
FR (1) FR2189034B2 (enrdf_load_html_response)
GB (1) GB1434919A (enrdf_load_html_response)
LU (1) LU67790A1 (enrdf_load_html_response)
NL (1) NL7308267A (enrdf_load_html_response)
ZA (1) ZA734037B (enrdf_load_html_response)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20190232T1 (hr) 2013-04-17 2019-03-22 Sage Therapeutics, Inc. 19-nor c3,3-disupstituirani c21-n-pirazolil steroidi i postupci za njihovu upotrebu
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
US9365611B2 (en) 2013-04-17 2016-06-14 Sage Therapeutics, Inc. 19-NOR neuroactive steroids and methods of use thereof
HRP20210610T1 (hr) 2013-07-19 2021-05-28 Sage Therapeutics, Inc. Neuroaktivni steroidi, pripravci i njihove uporabe
EP3831387A1 (en) 2013-08-23 2021-06-09 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
PH12017500711B1 (en) 2014-10-16 2022-12-09 Sage Therapeutics Inc Compositions and methods for treating cns disorders
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3719029A1 (en) 2014-11-27 2020-10-07 Sage Therapeutics, Inc. Compositions for inducing sedation
PT3250210T (pt) 2015-01-26 2021-03-26 Sage Therapeutics Inc Composições e métodos para o tratamento de distúrbios do snc
WO2016134301A2 (en) 2015-02-20 2016-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2017296295B2 (en) 2016-07-11 2022-02-24 Sage Therapeutics, Inc. C7, C12, and C16 substituted neuroactive steroids and their methods of use
EP3481845B1 (en) 2016-07-11 2023-09-13 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
EP3976628A1 (en) 2019-05-31 2022-04-06 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (de) * 1942-04-25 1951-02-28 Nv Organon Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe.
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof
FR2118117B1 (enrdf_load_html_response) * 1970-12-17 1975-12-26 Glaxo Lab Ltd

Also Published As

Publication number Publication date
GB1434919A (en) 1976-05-12
DE2330342A1 (de) 1974-01-17
CA1040619A (en) 1978-10-17
DK136157B (da) 1977-08-22
BE800899R (fr) 1973-12-14
FR2189034A2 (enrdf_load_html_response) 1974-01-25
DK136157C (enrdf_load_html_response) 1978-01-23
FR2189034B2 (enrdf_load_html_response) 1977-01-21
NL7308267A (enrdf_load_html_response) 1973-12-18
AU5693773A (en) 1974-12-19
ZA734037B (en) 1974-05-29

Similar Documents

Publication Publication Date Title
FR2189034B2 (enrdf_load_html_response)
CS177125B2 (enrdf_load_html_response)
FR2177644B1 (enrdf_load_html_response)
FR2174004B1 (enrdf_load_html_response)
FR2168288A1 (enrdf_load_html_response)
JPS49116096A (enrdf_load_html_response)
JPS4914578U (enrdf_load_html_response)
CS167372B2 (enrdf_load_html_response)
JPS4994486A (enrdf_load_html_response)
CS173775B1 (enrdf_load_html_response)
JPS4931922A (enrdf_load_html_response)
FR2188672A5 (enrdf_load_html_response)
JPS4887871U (enrdf_load_html_response)
CS174120B2 (enrdf_load_html_response)
CS161620B1 (enrdf_load_html_response)
JPS4953741U (enrdf_load_html_response)
JPS497882A (enrdf_load_html_response)
CS178133B2 (enrdf_load_html_response)
CH571797A5 (enrdf_load_html_response)
CH562243A5 (enrdf_load_html_response)
CH566496A5 (enrdf_load_html_response)
SE7204026L (enrdf_load_html_response)
CH566825A (enrdf_load_html_response)
CH592070A5 (enrdf_load_html_response)
CH569946A5 (enrdf_load_html_response)